Juglanin

SKU: orb1217964

Description

Juglanin is a JNK activator. Juglanin with inflammation and anti-tumor activities. It can induce apoptosis and autophagy on human breast cancer cells.

Images & Validation

−

Key Properties

−

CAS Number	5041-67-8
MW	418.35
Purity	>98% (HPLC)
Formula	C₂₀H₁₆O₁₀
SMILES	O=C1C(O[C@H]2[C@@H]([C@H]([C@H](CO)O2)O)O)=C(C3=CC=C(O)C=C3)OC4=CC(O)=CC(O)=C14
Target	Apoptosis
Solubility	Methanol:16 mg/mL (38.25 mM; Need ultrasonic)

Bioactivity

−

In Vivo

Animal model: Tumor-transplanted mouse model. Dosage: 10-20 mg/kg. Administration: Intraperitoneal injection (i.p.), daily, 7 days. Result: Increased levels of cleaved Caspase-9 and Caspase-3, LC3BI, LC3BII and phosphorylated JNK. Increased dead cells and apoptosis proportion in juglanin-treated tumor tissues. Increase in mean areas that stained positively cleaved Caspase-3 in juglanin-treated tumor tissues. Animal model: C57BL6 male mice. Dosage: 10-30 mg/kg. Administration: Intraperitoneal injection (i.p.), 5 times weekly. Result: Increased number of platform crossings and expanded time in target quadrant. Decreased the expression level of α-synuclein, pro-inflammatory cytokines (IL-1β, TNF-α, IL-18 and COX-2), TLR-4, MyD88, CD14, Aβ, phosphorylation of Tau, Ibal and neurotrophic factor (BDNF). Reversed LPS-triggered effect on synaptic markers, up-regulating the expression of SYP, PSD-95 and SNAP-25.Restored TH levels in the hippocampus of mice in a dose-dependent manner. Decreased p-IKKα, p-IκBα and p-NF-κB levels combinated with LPS. Decreased the GFAP-positive cells. Animal model: C57BL/6 male mice. Dosage: 80 mg/kg. Administration: i. g. , daily, 1-21 days. Result: Improved the survial rate of the BLM (HY-108345)-treated mice. Decreased the expression of BALF, CXCL1, IL-6, TNF-α, MPO activity, TGF-β1, and its down-streaming proteins (fibronectin/MMP-9/α-SMA/collagen I). Reduced the number of total cells, neutrophils and macrophages in BALF.

In Vitro

Cell Viability Assay Cell line: MCR-5 cell. Concentration: 0-40 μM. Incubation time: 0-72 h. Result: Reduced the cell viability of MCR-5 after 24 h exposure at 160 μM. Reduced the cell viability of MCR-5 after 72 h exposure at 40 μM. Western blot analysis. Cell line: MCF-7, SKBR3. Concentration: 0-10 μM. Incubation time: 24 h. Result: Increased the expressions of phosphorylated Chk2, Chk2, phosphorylated Cdc25C, phosphorylated Cdc2, p27, cyclin D, Bad, Bax and decreased the levels of Cdc25C, Cdc2, Bcl-2.Activated caspases and led to Casapse-9, Casapse-8 and Caspase-3 cleavage. Increased the level of JNK phosphorylation. Western blot analysis. Cell line: Lipopolysaccharides (LPS, HY-D1056)-treated AST cells. Concentration: 40-160 μM. Incubation time: 24 h. Result: Decreased the expression of TLR4, MyD88, CD14, p-IKKα, p-IκBα, p-NF-κB, GFAP, BDNF, Aβ and p-Tau induced by LPS (HY-D1056). Increased the level of SYP, PSD-25 and SNAP-25.

Storage & Handling

−

Storage	Storage temperature: -20°C. Stability: ≥ 2 years
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

Apoptosis

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols

Juglanin (orb1217964)

Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

No reviews yet

Purity:	99.33%
CAS Number:	5041-67-8
MW:	418.35
Formula:	C₂₀H₁₈O₁₀

Juglanin

Description

Images & Validation

Key Properties

Bioactivity

Storage & Handling

Similar Products

Juglanin [orb1296212]

Quality Guarantee

Quick Database Links

Documents Download

Request a Document

Protocol Information

Juglanin (orb1217964)

Step 1: Enter information below

Step 2: Enter the in vivo formulation

Available Sizes

Email

UK Office

US Office

CN Office

Distributors